Structures by: Lopez de Diego H. E.
Total: 7
C32H35NO9
C32H35NO9
Acta Crystallographica Section C (1995) 51, 2 253-256
a=9.7196(13)Å b=9.848(2)Å c=30.923(7)Å
α=90.° β=90.° γ=90.°
Gaboxadol hydrochloride
C6H9N2O2,Cl
Acta Crystallographica Section C (2013) 69, 11 1234-1237
a=6.6783(3)Å b=10.8766(6)Å c=11.2276(6)Å
α=100.668(2)° β=101.049(2)° γ=101.917(2)°
Gaboxadol hydrochloride
C6H9N2O2,Cl
Acta Crystallographica Section C (2013) 69, 11 1234-1237
a=13.1489(5)Å b=6.5780(2)Å c=17.0721(9)Å
α=90.00° β=90.4200(10)° γ=90.00°
Gaboxadol hydrochloride
C6H9N2O2,Cl
Acta Crystallographica Section C (2013) 69, 11 1234-1237
a=13.6018Å b=6.6783Å c=17.0168Å
α=89.683° β=92.077° γ=99.652°
Amlodipine besylate dihydrate
C26H35ClN2O10S
Crystal Growth & Design (2010) 10, 12 5279
a=19.1100(17)Å b=9.6240(9)Å c=16.6930(18)Å
α=90.000(10)° β=106.690(9)° γ=90.000(10)°
Amlodipine besylate dihydrate
C26H35ClN2O10S
Crystal Growth & Design (2010) 10, 12 5279
a=18.892(2)Å b=9.5070(6)Å c=16.357(3)Å
α=90.000° β=105.285(12)° γ=90.000°
Amlodipine besylate monohydrate
C20H26ClN2O5,C6H5SO3,H2O
Crystal Growth & Design (2010) 10, 12 5279
a=17.689(2)Å b=17.533(7)Å c=36.843(11)Å
α=90.0° β=90.182(17)° γ=90.0°